NTHI NeOnc Technologies Holdings, Inc.

NASDAQ
$4.22

NeOnc Technologies Holdings, Inc. (NTHI) is expected to report earnings on November 9, 2026, before the market open. The consensus earnings estimate is a loss of $0.16 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +21.6% since its last earnings release on August 10, 2026.

NeOnc Technologies Missed Consensus Estimates
Monday, August 10, 2026 · 9:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 9:00 AM ET
Earnings Whisper
-
vs ($0.16)
Rev est $999
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $3.86

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About NeOnc Technologies Holdings, Inc.

NeOnc Technologies Holdings Inc. is a biotechnology company focused on creating novel drugs and delivery methods for pharma-based therapeutics which target brain and central nervous system diseases. The company's principal product portfolio includes NEO 100. NeOnc Technologies Holdings Inc. is based in LOS ANGELES.

Sector

Healthcare

Industry

Biotechnology